Clinical use and mechanisms of resistance for PARP inhibitors in homologous recombination-deficient cancers

Cells are continuously subjected to DNA damaging agents. DNA damages are repaired by one of the many pathways guarding genomic integrity. When one or several DNA damage pathways are rendered inefficient, cells can accumulate mutations, which modify normal cellular pathways, favoring abnormal cell gr...

Descripción completa

Detalles Bibliográficos
Autores principales: Janysek, Dawn C., Kim, Jennifer, Duijf, Pascal H.G., Dray, Eloïse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2021
Materias:
Review article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847957/
https://www.ncbi.nlm.nih.gov/pubmed/33516088
http://dx.doi.org/10.1016/j.tranon.2021.101012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847957/
https://www.ncbi.nlm.nih.gov/pubmed/33516088
http://dx.doi.org/10.1016/j.tranon.2021.101012

Ejemplares similares